-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome
(2313) Views (448) Full article downloads
Authors: Hadi AR Hadi, Cornelia S Carr, Jassim Al Suwaidi
Published Date January 2005
Volume 2005:1(3) Pages 183 - 198
DOI: http://dx.doi.org/10.2147/VHRM.S
Hadi AR Hadi, Cornelia S Carr, Jassim Al Suwaidi
Department of Cardiology and Cardiovascular Surgery, Hamad General Hospital – Hamad Medical Corporation, Doha, State of Qatar
Abstract: Endothelial dysfunction is a well established response to cardiovascular risk factors and precedes the development of atherosclerosis. Endothelial dysfunction is involved in lesion formation by the promotion of both the early and late mechanisms of atherosclerosis including up-regulation of adhesion molecules, increased chemokine secretion and leukocyte adherence, increased cell permeability, enhanced low-density lipoprotein oxidation, platelet activation, cytokine elaboration, and vascular smooth muscle cell proliferation and migration. Endothelial dysfunction is a term that covers diminished production/availability of nitric oxide and/or an imbalance in the relative contribution of endothelium-derived relaxing and contracting factors. Also, when cardiovascular risk factors are treated the endothelial dysfunction is reversed and it is an independent predictor of cardiac events. We review the literature concerning endothelial dysfunction in regard to its pathogenesis, treatment, and outcome.
Keywords: endothelial dysfunction, coronary atherosclerosis, coronary artery disease
Readers of this article also read:
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Medical treatment of Cushing's disease: Overview and recent findings
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Activities of key glycolytic enzymes in the plasma of Saudi autistic patients
The role of rasagiline in the treatment of Parkinson’s disease
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors
Erratum - Intracellular heavy metal nanoparticle storage
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




